Spyre Therapeutics Inc. (SYRE) financials · $7.60B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Spyre Therapeutics Inc. (SYRE) $7.60B cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | N/A |
| Operating Income | -$209.6M | -$208.6M |
| Net Income | -$155.2M | -$208.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $777.8M | $608.5M |
| Current Assets | $777.8M | $608.5M |
| Cash & Equivalents | $85.7M | $89.4M |
| Total Liabilities | $62.5M | $90.7M |
| Current Liabilities | $58.7M | $54.1M |
| Shareholders' Equity | $715.2M | $517.8M |
| Retained Earnings | -$1.13B | -$972.4M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$169.3M | -$157.4M |
| CapEx | N/A | N/A |
| Investing Cash Flow | -$143.5M | -$353.3M |
| Financing Cash Flow | $309.0M | $410.9M |
| Net Change in Cash | -$3.70M | -$99.8M |
| Free Cash Flow | N/A | -$157.4M |
FAQ
What is SYRE P/E and revenue?
Spyre Therapeutics Inc. (SYRE) $7.60B cap.
What is SYRE revenue?
SYRE income-statement cache has no revenue figure yet.
Is SYRE profitable?
Spyre Therapeutics Inc. last cached net income is -$155.2M (FY2025).
What are SYRE total assets?
Spyre Therapeutics Inc. last cached total assets are $777.8M (FY2025).
What is SYRE free cash flow?
No cached cash-flow row for SYRE yet.
Not investment advice. Cached statements, not a live tape.